A$3.83
0.79%
Australia, Oct 08, 04:10 pm AEDT. Closed.
ISIN
AU0000013559
Symbol
ALX

Atlas Arteria Target price 2026 - Analyst rating & recommendation

Atlas Arteria Classifications & Recommendation

Buy
7%
Hold
43%
Sell
50%

Atlas Arteria Price Target

Target Price A$4.81
Price A$3.83
Potential
Number of Estimates 9
9 Analysts have issued a price target Atlas Arteria 2027 . The average Atlas Arteria target price is A$4.81. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 14 analysts: 1 Analysts recommend Atlas Arteria to buy, 6 to hold and 7 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Atlas Arteria stock has an average upside potential 2027 of . Most analysts recommend the Atlas Arteria stock at Sale.

Sales and Margin forecast 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Million A$ 160.00 158.18
9.66% 1.14%
EBITDA Margin 30.31% 897.08%
50.47% 2,859.44%
Net Margin 113.63% 103.06%
44.78% 9.30%

10 Analysts have issued a sales forecast Atlas Arteria 2026 . The average Atlas Arteria sales estimate is

A$158m
unlock
. This is
0.88% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
A$178m 13.37%
unlock
, the lowest is
A$150m 4.42%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 A$160m 9.66%
2026
A$158m 1.14%
unlock
2027
A$167m 5.56%
unlock
2028
A$177m 6.03%
unlock
2029
A$195m 10.00%
unlock
2030
A$204m 4.65%
unlock
2031
A$213m 4.66%
unlock
2032
A$223m 4.66%
unlock
2033
A$234m 4.65%
unlock

10 Analysts have issued an Atlas Arteria EBITDA forecast 2026. The average Atlas Arteria EBITDA estimate is

A$1.4b
unlock
. This is
1,273.70% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
A$1.5b 1,375.43%
unlock
, the lowest is
A$1.3b 1,190.16%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 A$48.5m 45.69%
2026
A$1.4b 2,825.77%
unlock
2027
A$1.5b 4.58%
unlock
2028
A$1.6b 4.65%
unlock

EBITDA Margin

2025 30.31% 50.47%
2026
897.08% 2,859.44%
unlock
2027
888.78% 0.93%
unlock
2028
877.25% 1.30%
unlock

10 Atlas Arteria Analysts have issued a net profit forecast 2026. The average Atlas Arteria net profit estimate is

A$163m
unlock
. This is
363.13% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
A$411m 1,068.49%
unlock
, the lowest is
A$37.0m 5.03%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 A$182m 39.44%
2026
A$163m 10.33%
unlock
2027
A$344m 110.78%
unlock
2028
A$384m 11.87%
unlock

Net Margin

2025 113.63% 44.78%
2026
103.06% 9.30%
unlock
2027
205.80% 99.69%
unlock
2028
217.14% 5.51%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share A$ 0.13 0.11
38.10% 15.38%
P/E 33.82
EV/Sales 43.72

10 Analysts have issued a Atlas Arteria forecast for earnings per share. The average Atlas Arteria EPS is

A$0.11
unlock
. This is
450.00% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
A$0.28 1,300.00%
unlock
, the lowest is
A$0.03 50.00%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 A$0.13 38.10%
2026
A$0.11 15.38%
unlock
2027
A$0.24 118.18%
unlock
2028
A$0.26 8.33%
unlock
2029
A$1.14 338.46%
unlock

P/E ratio

Current 190.00 634.77%
2026
33.82 82.20%
unlock
2027
16.04 52.57%
unlock
2028
14.34 10.60%
unlock

Based on analysts' sales estimates for 2026, the Atlas Arteria stock is valued at an EV/Sales of

43.72
unlock
and an P/S ratio of
35.10
unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 44.10 19.95%
2026
43.72 0.86%
unlock
2027
41.42 5.26%
unlock
2028
39.06 5.68%
unlock
2029
35.51 9.09%
unlock
2030
33.93 4.45%
unlock
2031
32.42 4.45%
unlock
2032
30.98 4.45%
unlock
2033
29.60 4.45%
unlock

P/S ratio

Current 35.41 22.92%
2026
35.10 0.87%
unlock
2027
33.25 5.26%
unlock
2028
31.36 5.68%
unlock
2029
28.51 9.09%
unlock
2030
27.24 4.45%
unlock
2031
26.03 4.45%
unlock
2032
24.87 4.45%
unlock
2033
23.77 4.45%
unlock

Current Atlas Arteria Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
MACQUARIE RESEARCH
Locked
➜
Locked
Locked Aug 28 2026
JEFFERIES
Locked
➜
Locked
Locked Aug 27 2026
JEFFERIES
Locked
➜
Locked
Locked Jun 22 2026
JEFFERIES
Locked
➜
Locked
Locked Jun 21 2026
MACQUARIE RESEARCH
Locked
➜
Locked
Locked Apr 22 2026
MACQUARIE RESEARCH
Locked
➜
Locked
Locked Apr 21 2026
MACQUARIE RESEARCH
Locked
➜
Locked
Locked Mar 02 2026
Analyst Rating Date
Locked
MACQUARIE RESEARCH:
Locked
➜
Locked
Aug 28 2026
Locked
JEFFERIES:
Locked
➜
Locked
Aug 27 2026
Locked
JEFFERIES:
Locked
➜
Locked
Jun 22 2026
Locked
JEFFERIES:
Locked
➜
Locked
Jun 21 2026
Locked
MACQUARIE RESEARCH:
Locked
➜
Locked
Apr 22 2026
Locked
MACQUARIE RESEARCH:
Locked
➜
Locked
Apr 21 2026
Locked
MACQUARIE RESEARCH:
Locked
➜
Locked
Mar 02 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today